Browse drugs

…der women. Overall, 94.4% reported ≥1 guideline-based potential PrEP indication. Based on the cumulative risk score, 3.6% reported 0…

…ion of PrEP users.Material and Methods Retrospective study. All PrEP users followed at the Infectious Diseases Day Hospital of Perug…

…2–35 times more people of White than Black ethnicity prescribed PrEP (ranges reflect variation across triangulated PrEP need denomin…

…ed after accessing a local public PrEP center.Conclusions While PrEP reimbursement is a landmark achievement, universal access remai…

…-Behaviour change (COM-B) model, the pilot aimed to improve HIV/PrEP knowledge/capability and motivation through pharmacist and comm…

… broad assessment of whether pharmacies are suitable venues for PrEP delivery to FSWs in Kampala. Enrolment will begin by April 2026…

… to estimate associations between discrimination and early oral PrEP discontinuation within 3 months of initiation, adjusting for co…

… mild pain at the injection site as a side effect of injectable PrEP. Compared with Australian-born, overseas-born MSM preferred PrE…

…t (from the previous year). Incidence was further stratified by PrEP use in 2022/2023.Results The number of HIV-negative GBMSM atten…

…EP. Recurrent condom and risk reduction counselling during oral PrEP uptake is crucial for preventing CAS. Self-risk assessment and …

… Sexually transmitted infections (STIs) incidence is high among PrEP cohorts, driven by high-risk sexual behaviours and systematic a…

…, cisgender women remain underrepresented in PrEP programs. Low PrEP uptake in this population may reflect perceived low HIV risk, y…